Evidence map›Paper›PMID 40611668›Full record

ArticleJournal of Parkinson's disease2025

Parkinson's disease associated with

Rafi Hadad, Roy N Alcalay, Inna Senderova, Maria Nassar, Andjelika Milicic, Judith Aharon Peretz, Isabel Elaine Allen, Rachel Ben-Hayun, Natalia Chasnyk, Ilham Morani and 3 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rafi HadadDepartment of Neurology, Stroke and Cognition Institute, Haifa, Israel.ORCID 0000-0003-4584-3055
Roy N AlcalayTel Aviv School of Medicine, Tel Aviv, Israel.ORCID 0000-0002-5717-4875
Inna SenderovaDepartment of Neurology, Movements Disorders Institute, Haifa, Israel.
Maria NassarDepartment of Neurology, Movements Disorders Institute, Haifa, Israel.ORCID 0009-0001-2418-1091
Andjelika MilicicGlobal Brain Health Institute, Department of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0003-3872-2167
Judith Aharon PeretzDepartment of Neurology, Stroke and Cognition Institute, Haifa, Israel.
Isabel Elaine AllenGlobal Brain Health Institute, Department of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0001-9029-9744
Rachel Ben-HayunDepartment of Neurology, Stroke and Cognition Institute, Haifa, Israel.
Natalia ChasnykDepartment of Neurology, Tzafon Medical Center, Poria, Israel.
Ilham MoraniGenetic laboratory, Ziv Medical Center, Safed, Israel.ORCID 0009-0003-5068-1318
Nadav ElkoshiLaboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.ORCID 0000-0003-4546-2922
Victor ValcourGlobal Brain Health Institute, Department of Neurology, University of California, San Francisco, CA, USA.
Ilana SchlesingerDepartment of Neurology, Movements Disorders Institute, Haifa, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the leucine-rich repeat kinase 2 (

Indexed as

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2MutationParkinson DiseaseAgedArabsEuropean PeopleFemaleHumansJewsMaleMiddle AgedLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humancognitive dysfunctiongenetic variationhumanLRRK2 proteinmutationParkinson’s disease

Identifiers

PMID40611668
PMCPMC13347503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.